| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 抗感染药(元) | 79,933,527.97 | 177,358,519.57 | 80,630,700.49 | 173,496,784.29 | 80,041,314.17 |
| 抗过敏药(元) | - | 66,166,253.57 | - | 166,325,185.36 | 85,159,841.48 |
| 泌尿系统药(元) | 86,967,314.47 | 165,062,202.32 | 74,693,752.65 | 128,562,877.13 | 57,734,502.33 |
| 保健食品(元) | - | 12,541,712.30 | - | 10,727,412.67 | - |
| 儿童用药(元) | - | 67,168,029.59 | 38,076,711.20 | 69,545,897.84 | - |
| 服务(元) | - | 26,755,254.90 | - | 33,799,193.51 | - |
| 呼吸系统药(元) | - | 57,842,521.02 | - | 39,144,454.43 | - |
| 商业(元) | - | 792,298.14 | - | 462,853.06 | - |
| 肾病药(元) | - | 26,302,199.88 | - | 37,147,539.32 | - |
| 医药原料及中间体(元) | - | 56,776,769.87 | - | 46,227,876.16 | - |
| 其他药品(元) | 86,957,032.98 | 135,649,852.90 | 49,573,734.63 | 119,402,047.44 | 68,599,669.43 |
| 营业成本(元) | |||||
| 抗感染药(元) | 16,245,488.36 | 34,133,478.14 | 15,991,023.24 | 32,033,969.65 | 15,245,353.49 |
| 抗过敏药(元) | - | - | - | 23,055,681.28 | 12,129,177.59 |
| 泌尿系统药(元) | 24,571,583.94 | 47,753,525.42 | 21,592,317.65 | 38,456,332.51 | 16,666,199.25 |
| 保健食品(元) | - | - | - | - | - |
| 儿童用药(元) | - | - | 17,142,948.99 | - | - |
| 服务(元) | - | - | - | - | - |
| 呼吸系统药(元) | - | - | - | - | - |
| 商业(元) | - | - | - | - | - |
| 肾病药(元) | - | - | - | - | - |
| 医药原料及中间体(元) | - | - | - | - | - |
| 其他药品(元) | 17,801,669.41 | 30,982,079.36 | 13,894,993.87 | 39,764,333.14 | 26,400,045.83 |
| 毛利(元) | |||||
| 抗感染药(元) | 63,688,039.61 | 143,225,041.43 | 64,639,677.25 | 141,462,814.64 | 64,795,960.68 |
| 抗过敏药(元) | - | - | - | 143,269,504.08 | 73,030,663.89 |
| 泌尿系统药(元) | 62,395,730.53 | 117,308,676.90 | 53,101,435.00 | 90,106,544.62 | 41,068,303.08 |
| 保健食品(元) | - | - | - | - | - |
| 儿童用药(元) | - | - | 20,933,762.21 | - | - |
| 服务(元) | - | - | - | - | - |
| 呼吸系统药(元) | - | - | - | - | - |
| 商业(元) | - | - | - | - | - |
| 肾病药(元) | - | - | - | - | - |
| 医药原料及中间体(元) | - | - | - | - | - |
| 其他药品(元) | 69,155,363.57 | 104,667,773.54 | 35,678,740.76 | 79,637,714.30 | 42,199,623.60 |
| 毛利率(%) | |||||
| 抗感染药(%) | 79.68 | 80.75 | 80.17 | 81.54 | 80.95 |
| 抗过敏药(%) | - | - | - | 86.14 | 85.76 |
| 泌尿系统药(%) | 71.75 | 71.07 | 71.09 | 70.09 | 71.13 |
| 保健食品(%) | - | - | - | - | - |
| 儿童用药(%) | - | - | 54.98 | - | - |
| 服务(%) | - | - | - | - | - |
| 呼吸系统药(%) | - | - | - | - | - |
| 商业(%) | - | - | - | - | - |
| 肾病药(%) | - | - | - | - | - |
| 医药原料及中间体(%) | - | - | - | - | - |
| 其他药品(%) | 79.53 | 77.16 | 71.97 | 66.70 | 61.52 |
| 收入构成(%) | |||||
| 抗感染药(%) | 31.49 | 22.38 | 33.18 | 21.03 | 27.46 |
| 抗过敏药(%) | - | 8.35 | - | 20.16 | 29.21 |
| 泌尿系统药(%) | 34.26 | 20.83 | 30.74 | 15.59 | 19.80 |
| 保健食品(%) | - | 1.58 | - | 1.30 | - |
| 儿童用药(%) | - | 8.48 | 15.67 | 8.43 | - |
| 服务(%) | - | 3.38 | - | 4.10 | - |
| 呼吸系统药(%) | - | 7.30 | - | 4.75 | - |
| 商业(%) | - | 0.10 | - | 0.06 | - |
| 肾病药(%) | - | 3.32 | - | 4.50 | - |
| 医药原料及中间体(%) | - | 7.17 | - | 5.60 | - |
| 其他药品(%) | 34.25 | 17.12 | 20.40 | 14.48 | 23.53 |
| 毛利构成(%) | |||||
| 抗感染药(%) | 32.62 | 39.22 | 37.07 | 31.13 | 29.31 |
| 抗过敏药(%) | - | 0.00 | - | 31.52 | 33.03 |
| 泌尿系统药(%) | 31.96 | 32.12 | 30.46 | 19.83 | 18.57 |
| 保健食品(%) | - | 0.00 | - | 0.00 | - |
| 儿童用药(%) | - | 0.00 | 12.01 | 0.00 | - |
| 服务(%) | - | 0.00 | - | 0.00 | - |
| 呼吸系统药(%) | - | 0.00 | - | 0.00 | - |
| 商业(%) | - | 0.00 | - | 0.00 | - |
| 肾病药(%) | - | 0.00 | - | 0.00 | - |
| 医药原料及中间体(%) | - | 0.00 | - | 0.00 | - |
| 其他药品(%) | 35.42 | 28.66 | 20.46 | 17.52 | 19.09 |